An inverse association between serum vitamin D levels with the presence and severity of impaired nerve conduction velocity and large fiber peripheral neuropathy in diabetic subjects

Neurological Sciences

Volumn 36, Issue 7, 2015, Pages 1121-1126

  Alamdari, Azam ^a   Mozafari, Rambod ^a   Tafakhori, Abbas ^a   Faghihi Kashani, Sara ^a,b   Hafezi Nejad, Nima ^b   Sheikhbahaei, Sara ^b   Naderi, Neda ^a   Ebadi, Maryam ^b   Esteghamati, Alireza ^b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

25 Hydroxyvitamin D; Adult; Diabetes mellitus; Diabetic neuropathy; Large fiber neuropathy; Nerve conduction velocity

Indexed keywords

25 HYDROXYVITAMIN D; CREATININE; GLIBENCLAMIDE; HEMOGLOBIN A1C; METFORMIN; PIOGLITAZONE; 25-HYDROXYVITAMIN D; VITAMIN D;

ADULT; AGE; ARTICLE; BODY HEIGHT; BODY MASS; CASE CONTROL STUDY; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; DEMOGRAPHY; DIABETIC NEUROPATHY; DIABETIC PATIENT; DIABETIC RETINOPATHY; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; FEMALE; HOFFMANN REFLEX; HUMAN; HYPERTENSION; LARGE FIBER PERIPHERAL NEUROPATHY; MALE; MICROALBUMINURIA; MONOTHERAPY; NERVE CONDUCTION; NERVE CONDUCTION DISORDER; NERVE FIBER; VITAMIN BLOOD LEVEL; ALBUMINURIA; ANALOGS AND DERIVATIVES; BLOOD; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; STATISTICAL MODEL; STATISTICS;

ADULT; ALBUMINURIA; CASE-CONTROL STUDIES; DIABETIC NEUROPATHIES; FEMALE; HUMANS; HYPERTENSION; LINEAR MODELS; MALE; METFORMIN; MIDDLE AGED; NEURAL CONDUCTION; STATISTICS AS TOPIC; VITAMIN D;

EID: 84933670320     PISSN: 15901874     EISSN: 15903478     Source Type: Journal    
DOI: 10.1007/s10072-015-2207-0     Document Type: Article

References (39)

1. Calvo MS, Whiting SJ, Barton CN (2005) Vitamin D intake: a global perspective of current status. J Nutr 135(2):310–316
2. Gannage-Yared MH, Chemali R, Yaacoub N, Halaby G (2000) Hypovitaminosis D in a sunny country: relation to lifestyle and bone markers. J Bone Miner Res 15(9):1856–1862. doi:10.1359/jbmr.2000.15.9.1856
3. Forrest KY, Stuhldreher WL (2011) Prevalence and correlates of vitamin D deficiency in US adults. Nutr Res 31(1):48–54. doi:10.1016/j.nutres.2010.12.001
4. Allali F, El Aichaoui S, Khazani H, Benyahia B, Saoud B, El Kabbaj S, Bahiri R, Abouqal R, Hajjaj-Hassouni N (2009) High prevalence of hypovitaminosis D in Morocco: relationship to lifestyle, physical performance, bone markers, and bone mineral density. Semin Arthritis Rheum 38(6):444–451. doi:10.1016/j.semarthrit.2008.01.009
5. Baz-Hecht M, Goldfine AB (2010) The impact of vitamin D deficiency on diabetes and cardiovascular risk. Curr Opin Endocrinol Diabetes Obes 17(2):113–119. doi:10.1097/MED.0b013e3283372859
6. Mezza T, Muscogiuri G, Sorice GP, Prioletta A, Salomone E, Pontecorvi A, Giaccari A (2012) Vitamin D deficiency: a new risk factor for type 2 diabetes? Ann Nutr Metab 61(4):337–348. doi:10.1159/000342771
7. Hirani V, Cumming RG, Le Couteur DG, Naganathan V, Blyth F, Handelsman DJ, Waite LM, Seibel MJ (2014) Low levels of 25-hydroxy vitamin D and active 1,25-dihydroxyvitamin D independently associated with type 2 diabetes mellitus in older Australian men: the concord health and ageing in men project. J Am Geriatr Soc. doi:10.1111/jgs.12975
8. Min B (2013) Effects of vitamin D on blood pressure and endothelial function. Korean J Physiol Pharmacol 17(5):385–392. doi:10.4196/kjpp.2013.17.5.385
9. Ku YC, Liu ME, Ku CS, Liu TY, Lin SL (2013) Relationship between vitamin D deficiency and cardiovascular disease. World J Cardiol 5(9):337–346. doi:10.4330/wjc.v5.i9.337
10. Espie M, Wassermann J, de Kermadec E, Lalloum M, Coussy F (2013) Vitamin D and cancers. Presse Med 42(10):1405–1411. doi:10.1016/j.lpm.2013.07.013
11. Holick MF (2008) Diabetes and the vitamin d connection. Curr Diab Rep 8(5):393–398
12. Chiu KC, Chu A, Go VL, Saad MF (2004) Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J Clin Nutr 79(5):820–825
13. Borissova AM, Tankova T, Kirilov G, Dakovska L, Kovacheva R (2003) The effect of vitamin D3 on insulin secretion and peripheral insulin sensitivity in type 2 diabetic patients. Int J Clin Pract 57(4):258–261
14. Washington RE, Andrews RM, Mutter R (2013) Emergency Department Visits for Adults with Diabetes, 2010. HCUP Statistical Brief #167. Agency for Healthcare Research and Quality, Rockville
15. Peltier A, Goutman SA, Callaghan BC (2014) Painful diabetic neuropathy. BMJ (Clinical research ed) 348:g1799. doi:10.1136/bmj.g1799
16. Argoff CE, Cole BE, Fishbain DA, Irving GA (2006) Diabetic peripheral neuropathic pain: clinical and quality-of-life issues. Mayo Clin Proc 81(4 Suppl):S3–11
17. Handevidt F (2001) Peripheral neuropathy in persons with diabetes. Clin Excell Nurse Pract 5(1):17–20
18. Pasnoor M, Dimachkie MM, Kluding P, Barohn RJ (2013) Diabetic neuropathy part 1: overview and symmetric phenotypes. Neurol Clin 31(2):425–445. doi:10.1016/j.ncl.2013.02.004
19. (1995) Effect of intensive diabetes treatment on nerve conduction in the diabetes control and complications trial. Ann Neurol 38 (6):869–880. doi:10.1002/ana.410380607
20. Soderstrom LH, Johnson SP, Diaz VA, Mainous AG 3rd (2012) Association between vitamin D and diabetic neuropathy in a nationally representative sample: results from 2001–2004 NHANES. Diabet Med 29(1):50–55. doi:10.1111/j.1464-5491.2011.03379.x
21. Shehab D, Al-Jarallah K, Mojiminiyi OA, Al Mohamedy H, Abdella NA (2012) Does vitamin D deficiency play a role in peripheral neuropathy in type 2 diabetes? Diabet Med 29(1):43–49. doi:10.1111/j.1464-5491.2011.03510.x
22. Celikbilek A, Gocmen AY, Tanik N, Borekci E, Adam M, Celikbilek M, Suher M, Delibas N (2014) Decreased serum vitamin D levels are associated with diabetic peripheral neuropathy in a rural area of Turkey. Acta Neurol Belg. doi:10.1007/s13760-014-0304-0
23. Bajaj S, Singh RP, Dwivedi NC, Singh K, Gupta A, Mathur M (2014) Vitamin D levels and microvascular complications in type 2 diabetes. Indian J Endocrinol Metab 18(4):537–541. doi:10.4103/2230-8210.137512
24. American Diabetes Association (2012) Standards of medical care in diabetes—2012. Diabetes Care 35(Suppl 1):S11–S63. doi:10.2337/dc12-s011
25. Esteghamati A, Hafezi-Nejad N, Zandieh A, Sheikhbahaei S, Emamzadeh-Fard S, Nakhjavani M (2014) CA 19-9 is associated with poor glycemic control in diabetic patients: role of insulin resistance. Clin Lab 60(3):441–447
26. Kimura J (1978) A method for determining median nerve conduction velocity across the carpal tunnel. J Neurol Sci 38(1):1–10
27. Preston DC, Shapiro BE (2013) Basic nerve conduction studies. In: Shapiro DCPE (ed) Electromyography and Neuromuscular Disorders, 3rd edn. W.B. Saunders, London, pp 19–35
28. Dyck PJ, Carter RE, Litchy WJ (2011) Modeling nerve conduction criteria for diagnosis of diabetic polyneuropathy. Muscle Nerve 44(3):340–345. doi:10.1002/mus.22074
29. Skalli S, Muller M, Pradines S, Halimi S, Wion-Barbot N (2012) Vitamin D deficiency and peripheral diabetic neuropathy. Eur J Intern Med 23(2):e67–e68. doi:10.1016/j.ejim.2011.11.008
30. Putz Z, Martos T, Nemeth N, Korei AE, Szabo M, Vagi OE, Kempler MS, Kempler P (2013) Vitamin D and neuropathy. Orv Hetil 154(51):2012–2015. doi:10.1556/oh.2013.29769
31. Lv WS, Zhao WJ, Gong SL, Fang DD, Wang B, Fu ZJ, Yan SL, Wang YG (2014) Serum 25-hydroxyvitamin D levels and peripheral neuropathy in patients with type 2 diabetes: a systematic review and meta-analysis. J Endocrinol Invest. doi:10.1007/s40618-014-0210-6
32. Ahmadieh H, Azar ST, Lakkis N, Arabi A (2013) Hypovitaminosis d in patients with type 2 diabetes mellitus: a relation to disease control and complications. ISRN Endocrinol 2013:641098. doi:10.1155/2013/641098
33. Knekt P, Kilkkinen A, Rissanen H, Marniemi J, Saaksjarvi K, Heliovaara M (2010) Serum vitamin D and the risk of Parkinson disease. Arch Neurol 67(7):808–811. doi:10.1001/archneurol.2010.120
34. Burton JM, Kimball S, Vieth R, Bar-Or A, Dosch HM, Cheung R, Gagne D, D’Souza C, Ursell M, O’Connor P (2010) A phase I/II dose-escalation trial of vitamin D3 and calcium in multiple sclerosis. Neurology 74(23):1852–1859. doi:10.1212/WNL.0b013e3181e1cec2
35. Riaz S, Malcangio M, Miller M, Tomlinson DR (1999) A vitamin D(3) derivative (CB1093) induces nerve growth factor and prevents neurotrophic deficits in streptozotocin-diabetic rats. Diabetologia 42(11):1308–1313. doi:10.1007/s001250051443
36. Samina Riaz S, Tomlinson DR (2000) Pharmacological modulation of nerve growth factor synthesis: a mechanistic comparison of vitamin D receptor and beta(2)-adrenoceptor agonists. Brain Res Mol Brain Res 85(1–2):179–188
37. Lee P, Chen R (2008) Vitamin D as an analgesic for patients with type 2 diabetes and neuropathic pain. Arch Intern Med 168(7):771–772. doi:10.1001/archinte.168.7.771
38. Valensi P, Le Devehat C, Richard JL, Farez C, Khodabandehlou T, Rosenbloom RA, LeFante C (2005) A multicenter, double-blind, safety study of QR-333 for the treatment of symptomatic diabetic peripheral neuropathy. A preliminary report. J Diabetes Complicat 19(5):247–253. doi:10.1016/j.jdiacomp.2005.05.011
39. Bell DS (2012) Reversal of the symptoms of diabetic neuropathy through correction of vitamin D deficiency in a type 1 diabetic patient. Case Rep Endocrinol 2012:165056. doi:10.1155/2012/165056